CMP
BMY icon

Christine Messmer PC’s Bristol-Myers Squibb BMY Stock Holding History

Christine Messmer PC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$660K Buy
11,461
+1,633
+17% +$93.8K 0.37% 42
2026
Q1 		$596K Buy
9,828
+1,076
+12% +$62.7K 0.38% 42
2025
Q4 		$472K Buy
+8,752
New +$421K 0.31% 49

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Christine Messmer PC's BMY Position: Q2 2026 in Review

Christine Messmer PC increased its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2026, buying an estimated $93.8K and bringing the position to 11,461 shares worth $660K. The position accounts for 0.37% of the portfolio, ranked #42.

Christine Messmer PC first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Christine Messmer PC held 11,461 shares of Bristol-Myers Squibb worth $660K as of Q2 2026.
  • Christine Messmer PC bought 1,633 Bristol-Myers Squibb shares in Q2 2026, an estimated $93.8K.
  • Bristol-Myers Squibb made up 0.37% of Christine Messmer PC's portfolio in Q2 2026, its #42 holding.
  • Christine Messmer PC first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • 2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Christine Messmer PC's 13F filing for Q2 2026, filed 23 Jul 2026.